During the corresponding time, Solana Company recorded a revenue increase by 7289.8 % year on year, sequentially revenue fell by -30.74 %. While revenue at the Solana Company's corporate clients
Solana's Comment on Sales, Marketing and Customers
The company provides public market investors with direct exposure to Solana (SOL), a scalable, high-performance blockchain platform. Its digital asset treasury strategy involves acquiring and holding SOL to increase long-term shareholder value. The company seeks to enhance its digital asset treasury and create strategic optionality for product innovation within its core business. Additionally, the company identifies as a neurotechnology firm focused on neurological wellness. Its customer base includes public market investors interested in digital assets and blockchain technology, particularly those seeking exposure to Solana.
Helius Medical Technologies, Inc., a pioneer in novel therapeutic neuromodulation approaches, has announced its alliance with Shepherd Center for expanding its stroke clinical program focused on restoring walking mobility in stroke recovery patients. This partnership aligns with the company’s programmatic approach to broaden the labeling of its marketed PoNS device for stroke patients. This revolutionary move will see Shepherd Center join Brooks Rehabilitation, part of Helius U.S. registrational program as the third clinical site. Delivering renowned healthcare services for intensive and comprehensive rehabilitation to people with spinal cord injury and disease, brain injury, stroke, multiple sclerosis, a...
Helius Medical Technologies Secures Reimbursement Milestone for Revolutionary MS Treatment Device, Extends Financial Stability Until 2024In a significant development for the healthcare industry, Helius Medical Technologies, Inc. has successfully obtained HCPCS codes for their groundbreaking Portable Neuromodulation Stimulator (PoNS) Mouthpiece and Controller. This achievement marks a major step toward reimbursement for the only medical device approved in the U.S. for the treatment of gait deficit resulting from multiple sclerosis (MS).The PoNS device, manufactured by Helius Medical Technologies, Inc., combines neuromodulation and physical therapy to address the debilitating gait issues faced by MS patients. ...
Helius Medical Technologies, Inc. Expands Stroke Program and Sees Significant Revenue IncreaseIn an exciting development, Helius Medical Technologies, Inc. has announced the expansion of its stroke clinical program with the addition of Brooks Rehabilitation Hospital. This collaboration adds a second site to the registrational program in stroke, bringing the total number of patients participating to 100. The study conducted by Brooks Rehabilitation Hospital aims to evaluate the use of Portable Neuromodulation Stimulator (PoNS) for gait/balance deficits in stroke patients. This non-invasive neuromodulation technique holds the potential to revolutionize rehabilitation efforts for those recovering from stroke-re...
Solana’s Comment on Sales, Marketing and Customers
The company provides public market investors with direct exposure to Solana (SOL), a scalable, high-performance blockchain platform. Its digital asset treasury strategy involves acquiring and holding SOL to increase long-term shareholder value. The company seeks to enhance its digital asset treasury and create strategic optionality for product innovation within its core business. Additionally, the company identifies as a neurotechnology firm focused on neurological wellness. Its customer base includes public market investors interested in digital assets and blockchain technology, particularly those seeking exposure to Solana.
Sources:
Solana Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Solana Company’s corporate clients.
For your research, we’ve provided 9 tables on Solana Company corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
